Insider buying
~$3K501 sh @ $5.95
Traded Feb 10, 2025 · filed the same day
The CFO of Sensus Healthcare paid $3K out of pocket for Sensus Healthcare shares. 1 other person at Sensus Healthcare bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 10, 2025 · Filed Feb 10, 2025
A Sensus Healthcare director paid $6K out of pocket for Sensus Healthcare shares. 1 other person at Sensus Healthcare bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$5,950
Shares × reported transaction price
<$25K
+0.9%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
5 days after results of Feb 5, 2025, 94 days before results of May 15, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.5% | +1.0% | −2.5% |
| 30 days | −25.3% | −8.9% | −16.4% |
| 90 days | −23.3% | −3.7% | −19.6% |
| 180 days | −46.4% | +5.1% | −51.4% |
| 365 days | −19.7% | +14.3% | −34.0% |
Past results only. Not a forecast.
Insider buying
Traded Feb 10, 2025 · filed the same day
The CFO of Sensus Healthcare paid $3K out of pocket for Sensus Healthcare shares. 1 other person at Sensus Healthcare bought some too, in the same month.
Michael Sardano, PRESIDENT AND GENERAL COUNSEL's past purchases, 90 days after disclosure: 5 buys, median −7.2 pts vs S&P 500, beat it 2 of 5 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.